Meta-analysis of RCTs in adults with MDD and inadequate SSRI/SNRI response: adjunctive orexin receptor antagonists vs placebo modestly improved MADRS (MD −1.96) and PROMIS sleep scores (MD −3.39), not HAMD17; no clear safety difference. Few studies.
Meta-analysis
Pereira et al. Efficacy and safety of adjunctive orexin receptor antagonist therapy in major depressive disorder: A systematic review and meta-analysis of randomized controlled trials